Portable Bioprocessing Bioreactors Market Report 2026

The portable bioprocessing bioreactors market size has grown rapidly in recent years. It will grow from $2.8 billion in 2025 to $3.16 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to limited availability of portable bioreactors, reliance on traditional stainless steel and glass systems, growing academic research in cell culture and tissue engineering, increasing demand for biopharmaceuticals, development of vaccine production facilities.

The portable bioprocessing bioreactors market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to advancements in single-use and smart bioreactor technologies, increasing investment in cell therapy and regenerative medicine, expansion of contract research organizations (cros), integration of ai-driven monitoring and process automation, rising demand for point-of-care and on-site bioprocessing solutions. Major trends in the forecast period include rising adoption of single-use and smart bioreactors, expansion of cell therapy and regenerative medicine applications, growth in vaccine and biologics development programs, increasing focus on biopharmaceutical production efficiency, integration of remote monitoring and data analytics in bioreactor operations.

The escalating demand for gene therapies is poised to fuel the portable bioprocessing bioreactors market ahead. Gene therapy is a method that alters or substitutes flawed genes to tackle or forestall diseases. Its surge arises from leaps in genetic mapping and detection, permitting exact targeting of culprit genes. Portable bioprocessing bioreactors hasten gene therapies via on-location, adaptable production in managed, expandable setups. They cut timelines and intricacies, sharpening the pace and output of bespoke treatments. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US non-profit science organization, reported FDA nods rose to six gene therapy products in 2023 from five in 2022. Thus, the rising gene therapy demand is propelling the portable bioprocessing bioreactors market.

Key players in the portable bioprocessing bioreactors market are pioneering advanced gear like single-use bioreactors to boost adaptability and simplify cell therapy workflows. Single-use bioreactors employ throwaway, pre-sterile plastic bags over traditional reusables, speeding setup, slashing contamination risks, and trimming sanitation expenses in bioprocessing. For instance, in April 2025, Thermo Fisher Scientific, a US biotech giant, debuted the 5L DynaDrive single-use bioreactor, a state-of-the-art portable system for superior cell culture scaling and oversight. It supports fluid growth from 1 to 5,000 liters with uniform design and film integrity, yielding 27% higher productivity than glass models. Compact and intuitive for benchtop use, it features biobased films and BioTitan filters to minimize losses and advance eco-friendliness.

In June 2023, Donaldson Company Inc., a US filtration and materials tech firm, acquired Belgium's Univercells Technologies S.A. for €136 million. This deal expands Donaldson's life sciences arm by weaving in Univercells' platforms like the scale-X single-use bioreactor and NevoLine Upstream system, delivering comprehensive viral vector solutions. Univercells Technologies S.A. is a Belgium company expert in affordable biomanufacturing for cell/gene therapies, vaccines, and cutting-edge treatments.

Major companies operating in the portable bioprocessing bioreactors market are Thermo Fisher Scientific Inc., Merck KGaA, Cytiva Bioscience Holding Ltd., Sartorius AG, PBS Biotech Inc., Culture Biosciences Inc., FermEx Inc.

North America was the largest region in the portable bioprocessing bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the portable bioprocessing bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the portable bioprocessing bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the portable bioprocessing bioreactors market by increasing the cost of imported sensors, automation equipment, single-use bags, and stainless steel components. Segments like smart bioreactors and single-use bioreactors are most affected, particularly in regions like North America and Europe that rely on imports from Asia-Pacific manufacturing hubs. While tariffs have raised operational costs and slowed equipment deployment, they have also encouraged local manufacturing, investment in domestic R&D, and innovation in cost-effective, portable bioreactor solutions.

The portable bioprocessing bioreactors market research report is one of a series of new reports that provides portable bioprocessing bioreactors market statistics, including portable bioprocessing bioreactors industry global market size, regional shares, competitors with a portable bioprocessing bioreactors market share, detailed portable bioprocessing bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the portable bioprocessing bioreactors industry. This portable bioprocessing bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Portable bioprocessing bioreactors are compact, mobile systems designed to carry out controlled biological reactions and cell cultures outside conventional laboratory environments. They allow on-site bioprocessing with precise control over environmental conditions, improving flexibility and efficiency in research and production.

The main product types of portable bioprocessing bioreactors include single-use bioreactors, stainless steel bioreactors, glass bioreactors, multi-use bioreactors, and smart bioreactors. Single-use bioreactors are disposable, pre-sterilized cultivation systems intended for one-time use in bioprocessing, eliminating the need for cleaning and sterilization between batches. Their modes of operation include batch bioreactors, fed-batch bioreactors, continuous bioreactors, and perfusion bioreactors, and they are available in various capacities, such as 100-500 L, 50-100 L, 10-50 L, and 1-10 L. These bioreactors are applied in cell therapy and regenerative medicine, vaccine and biologic development, biopharmaceutical production, biologics and biosimilars manufacturing, and tissue engineering, serving end users such as academic and research institutions, biopharmaceutical companies, contract research organizations (CROs), food and beverage manufacturers, and chemical and petrochemical industries.

The portable bioprocessing bioreactors market consists of sales of hollow fiber bioreactors, fixed bed bioreactors, air-lift bioreactors, and wave-mixed bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.